These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8440570)

  • 1. [What is reliable in the treatment of osteoporosis in menopausal women?].
    Ziegler R
    Internist (Berl); 1993 Jan; 34(1):18-24. PubMed ID: 8440570
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stability also depends on other parameters. Bone density--not a good indicator for fracture prevention].
    MMW Fortschr Med; 2004 Aug; 146(31-32):53. PubMed ID: 15529718
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteoporosis from the gynecologic viewpoint].
    Schneider HP; Dören M
    Gynakologe; 1993 Apr; 26(2):83-92. PubMed ID: 8508989
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of progression of decreasing bone mass and manifest osteoporosis].
    Ringe JD
    Internist (Berl); 1993 Apr; 34(4):300-6. PubMed ID: 8486473
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estrogen replacement therapy in osteoporosis].
    Hirvonen E
    Duodecim; 1996; 112(22):2123-9. PubMed ID: 10605218
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical management of osteoporosis.
    Mulloy AL; Weinstein RS
    J Med Assoc Ga; 1994 Apr; 83(4):227-30. PubMed ID: 8006552
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a case for targeting hormone replacement therapy for osteoporosis at the menopause?
    Stevenson JC
    Osteoporos Int; 1998; 8 Suppl 1():S47-50. PubMed ID: 9682798
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene: bone and cardiovascular effects.
    Francucci CM; Romagni P; Boscaro M
    J Endocrinol Invest; 2005; 28(10 Suppl):85-9. PubMed ID: 16550730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of osteoporosis].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2003 Aug; 123(16):2263-4. PubMed ID: 14508549
    [No Abstract]   [Full Text] [Related]  

  • 12. Fracture prevention in postmenopausal women.
    Bruyere O; Reginster JY; Edwards J
    Clin Evid; 2002 Dec; (8):1089-102. PubMed ID: 12603931
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
    Col NF; Bowlby LA; McGarry K
    Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone densitometry and hormone therapy].
    Rizk P
    Pathol Biol (Paris); 1998 May; 46(5):291-3. PubMed ID: 9769887
    [No Abstract]   [Full Text] [Related]  

  • 15. [Osteoporosis therapy in general practice. Which measure should be included?].
    Abendroth K
    MMW Fortschr Med; 2002 Oct; 144(42):62. PubMed ID: 12534001
    [No Abstract]   [Full Text] [Related]  

  • 16. [Osteoporosis of the elderly person].
    Rivier E
    Rev Med Suisse Romande; 1996 Sep; 116(9):743-50. PubMed ID: 8966476
    [No Abstract]   [Full Text] [Related]  

  • 17. Fracture prevention in postmenopausal women.
    Bruyere O; Reginster JY
    Clin Evid; 2002 Jun; (7):979-82. PubMed ID: 12230720
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone density screening in females in climacteric].
    Heytmanek G
    Wien Med Wochenschr; 1992; 142(5-6):130-2. PubMed ID: 1615683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
    Kanis JA
    Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
    Watts NB
    J Reprod Med; 2002 Jan; 47(1 Suppl):82-92. PubMed ID: 11829081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.